Logo.png
Premier Information Management, Inc. Announces Reverse Merger With Cannabinoid Biosciences, Inc.
May 13, 2021 18:20 ET | Premier Information Management, Inc.
TORRANCE, May 13, 2021 (GLOBE NEWSWIRE) -- Premier Information Management, Inc. (OTC: PIFR) announced today that it has entered into a reverse merger agreement with Cannabinoid Biosciences, Inc. a...
Athira Pharma Logo RGB@1200px.jpg
Athira Pharma Reports First Quarter 2021 Financial Results and Provides Business Highlights
May 13, 2021 16:02 ET | Athira Pharma, Inc.
-Phase 2 trial initiation for Parkinson’s disease dementia program and IND submission for neuropsychiatric program planned by end of 2021- -Hosted educational webinar on targeting HGF/MET...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma
May 13, 2021 16:02 ET | PRA Health Sciences, Inc.
RALEIGH, N.C., May 13, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today an innovative tokenization solution using Synoma®, PRA’s proprietary technology that allows...
Gevo, Inc. Logo
Gevo Reports First Quarter 2021 Financial Results
May 13, 2021 16:01 ET | Gevo, Inc.
ENGLEWOOD, Colo., May 13, 2021 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) today announced financial results for the first quarter of 2021 and recent corporate highlights. Recent Corporate...
Cytovia.png
Cytovia Therapeutics Expands Leadership Team
May 13, 2021 09:48 ET | Cytovia Therapeutics
Jason Aryeh elected to Board of DirectorsElizabeth Schwarzbach, PhD and Boris Reznik, PhD join Strategic Advisory BoardElysa Mantel appointed as Vice President, General Counsel and Corporate Secretary...
lumos.png
Lumos Pharma to Participate in the Oppenheimer Rare & Orphan Disease Summit
May 13, 2021 09:00 ET | Lumos Pharma, Inc.
AUSTIN, Texas, May 13, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company...
Certara-CMYK-01.jpg
Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies
May 13, 2021 08:00 ET | Certara
PRINCETON, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), the global leader in biosimulation, today announced the launch of new versions of its Immunogenicity (IG) and...
PDS Biotech Logo.png
PDS Biotech Provides Business Update and Reports First Quarter 2021 Financial Results
May 13, 2021 07:00 ET | PDS Biotechnology Corporation
FLORHAM PARK, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease...
Adverum_Primary_Medium.png
Adverum Stockholders Re-Elect All Adverum Director Nominees at 2021 Annual Meeting
May 12, 2021 13:05 ET | Adverum Biotechnologies, Inc.
REDWOOD CITY, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases,...
Philogen logo.png
Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress
May 12, 2021 13:00 ET | Philogen
Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress May 12, 2021 NidlegyTM on track for Phase III European trial in stage IIIB/C melanoma. Opening of additional...